N2N Technologies Ltd (512279)
சுருக்கம்
நிகழ்வுகள்
- சமீபத்திய முடிவுகள்
- Q2 FY27, தாக்கல் செய்யப்பட்டது 2 நவ. 2026
- இயக்குநர் குழுக் கூட்ட அறிவிப்பு
- 2 நவ. 2026
பங்குச் சந்தைத் தரவு. ஒவ்வொரு எண்ணும் அதன் சொந்தப் பக்கம் காட்டும் வடிவத்திலேயே; தேதிகள் தரவின் தேதிகள். தகவலுக்கு மட்டுமே, முதலீட்டு ஆலோசனை அல்ல.
📈 பங்கு விலை & நிகழ்வுகள்
Q2 FY27 முடிவுகள்
N2N Technologies Ltd reported Q2 FY27 results on 2 Nov 2026: revenue ₹0.0 Cr (-99.9% year on year, -99.7% on the previous quarter), and net profit ₹-0.2 Cr; the operating margin was -52950.0%.
| Q2 FY27 (₹ கோடி) | மதிப்பு | YoY Q2 FY26-உடன் | QoQ |
|---|---|---|---|
| வருவாய் | ₹0.0 | -99.9% | -99.7% |
| செயல்பாட்டு லாபம் | ₹-0.2 | — | நஷ்டம் அதிகரித்தது |
| நிகர லாபம் | ₹-0.2 | — | நஷ்டம் அதிகரித்தது |
| EPS (₹) | -0.66 | — | நஷ்டம் அதிகரித்தது |
| செயல்பாட்டு லாப வரம்பு | -52950.0% | — | — |
📢 சமீபத்திய கார்ப்பரேட் அறிவிப்புகள்
N2N Technologies reported near-zero revenue of ₹0.04 lakh for the quarter ended September 30, 2026, down sharply from ₹32.02 lakh in Q2 FY26 and ₹15.20 lakh in Q1 FY27. The company incurred a net loss of ₹21.18 lakh during the quarter, compared to a profit of ₹0.33 lakh in the year-ago period. Total expenses stood at ₹21.22 lakh, largely driven by employee benefit expenses of ₹18.82 lakh. Alongside financial results, the board appointed Mr. Mehul Parekh as CEO and Mr. Firoze Kapadia as CFO, and scheduled its Annual General Meeting for December 22, 2026.
- Revenue from operations fell sharply to ₹0.04 lakh in Q2 ended Sept 30, 2026, versus ₹32.02 lakh in Q2 ended Sept 30, 2025
- Net loss widened to ₹21.18 lakh for Q2 FY27 compared to a net profit of ₹0.33 lakh in Q2 FY26
- Total expenses were ₹21.22 lakh, dominated by employee benefit expenses of ₹18.82 lakh
- H1 FY27 total revenue stood at ₹15.24 lakh with an aggregate net loss of ₹33.67 lakh
- Appointed Mr. Mehul Parekh as CEO and Mr. Firoze Kapadia as CFO effective November 02, 2026
N2N Technologies Limited announced the appointments of Mr. Mehul Parekh as Chief Executive Officer (CEO) and Mr. Firoze Kapadia as Chief Financial Officer (CFO), effective November 2, 2026. Both appointees currently serve as Directors of the micro-cap company (market cap ~Rs 11 Cr). Mr. Parekh brings over 40 years of pharmaceutical and API experience, while Mr. Kapadia has a background in the agro commodities business in West Africa. The board meeting approving these appointments commenced at 5:30 pm and concluded at 6:15 pm on November 2, 2026.
- Appointment of Mr. Mehul Parekh as Chief Executive Officer effective November 2, 2026
- Appointment of Mr. Firoze Kapadia as Chief Financial Officer effective November 2, 2026
- Mr. Parekh brings over 40 years of pharmaceutical industry experience
- Board meeting approving the appointments concluded in 45 minutes (5:30 pm to 6:15 pm)
BSE Limited has revoked the trading suspension of equity shares of N2N Technologies Ltd with effect from October 27, 2026. The suspension was originally imposed due to non-payment of Annual Listing Fees (ALF) under Regulation 14 of SEBI LODR Regulations. Following compliance and clearance of dues, trading will resume under the 'Z' Group in the Trade-to-Trade category. The company currently holds a micro-cap valuation of approximately Rs 11 Cr.
- Revocation of equity shares suspension effective October 27, 2026
- Trading permitted under 'Z' Group in the Trade-to-Trade category
- Action resolved defaults relating to Annual Listing Fees (ALF) non-payment under Regulation 14
- Exchange notice reference: Notice No. 20261022-33 dated October 22, 2026
N2N Technologies has announced the resignation of Director Mr. Rahul Dilip Shah with effect from September 24, 2026. The resignation follows a change in management and control resulting from an open offer made by Harmony Remedies Private Limited and PACs. Additionally, Mr. Shah stated an inability to devote requisite time due to being based in the United States. N2N Technologies holds a market capitalization of approximately ₹11 Cr.
- Director Mr. Rahul Dilip Shah stepped down effective September 24, 2026
- Resignation cited change in control following an Open Offer by Harmony Remedies Private Limited and PACs
- Director is based in the USA, citing inability to devote necessary time to affairs of the company
N2N Technologies Limited has received approval from the Registrar of Companies (ROC), Pune, extending the timeline to convene its Annual General Meeting (AGM) for FY 2025-2026 up to December 31, 2026. The extension follows a change in control and management stemming from an open offer concluded by Harmony Remedies Private Limited and PACs. With an equity market capitalization of just Rs 11 Cr, investors should monitor corporate governance and strategic shifts under the incoming management.
- ROC Pune granted extension to hold AGM for FY 2025-2026 until December 31, 2026
- Change in control and management noted following a recently concluded open offer
- Acquisition and open offer executed by Harmony Remedies Private Limited along with PACs
Mr. Tushar Shah has resigned from his roles as Director and Chief Financial Officer (CFO) of N2N Technologies Ltd, effective August 13, 2026. This resignation is a direct result of the change in management and control following a recently concluded Open Offer. The company is a micro-cap with a market capitalization of ₹11 Cr and is currently loss-making, reporting a net loss of ₹2.78 Cr for FY26 on a total revenue of just ₹1.34 Cr. Investors should monitor the incoming management team's strategy to address the negative operating margins of -210.6%.
- Resignation of Mr. Tushar Shah as Director and CFO effective August 13, 2026.
- Departure is linked to the change in control of the company pursuant to a recently concluded Open Offer.
- Company reported a significant net loss of ₹2.78 Cr in FY26 compared to a net worth of ₹4 Cr.
- TTM revenue stands at a minimal ₹1 Cr, highlighting the small scale of current operations.
- Operating Profit Margin (OPM) is deeply negative at -210.6% as per latest TTM data.
N2N Technologies has announced the complete cessation of its IT and Software Consulting business effective August 13, 2026. This move follows a change in management and control after a recently concluded Open Offer by Harmony Remedies Private Limited, Firoze Kapadia, and Aditi Parikh. The company has relieved all employees and consultants from its IT division, which accounted for its entire TTM revenue of Rs 1 Cr. The new management is currently evaluating new business opportunities, effectively turning the company into a shell entity pending a strategic pivot.
- Complete cessation of IT and Software Consulting business effective August 13, 2026
- All employees and consultants from the IT division have been relieved from service
- Change in control triggered by an Open Offer from Harmony Remedies Private Limited and associates
- Discontinuation of a business segment that generated Rs 1.34 Cr in FY26 revenue
- New business activities are currently under evaluation by the incoming management
N2N Technologies has reconstituted its board with 4 new director appointments effective August 12, 2026, following a change in management and control. This shift results from a recently concluded Open Offer by Harmony Remedies Pvt Ltd and associates. The new leadership includes professionals with 40+ years of pharmaceutical experience and agro-commodity backgrounds, which is significant for a company with a small market cap of Rs 11 Cr and a TTM revenue of only Rs 1 Cr. This move potentially signals a strategic turnaround for the currently loss-making entity (FY26 PAT of Rs -2.78 Cr).
- 4 Additional Directors appointed including a Chairman and two Executive Directors on August 12, 2026.
- Management control shifted to Harmony Remedies Pvt Ltd following a successful Open Offer.
- Mr. Mehul J. Parekh joins as Executive Director bringing 40+ years of pharmaceutical industry experience.
- The company is currently struggling with a TTM revenue of only Rs 1 Cr and an OPM of -210.6%.
- New board includes expertise in Treasury, Pharma, Agro-commodities, and Corporate Finance.
Harmony Remedies India Private Limited, along with two Persons Acting in Concert (PACs), has successfully taken management control of N2N Technologies effective August 13, 2026. This follows the completion of an Open Offer under SEBI Takeover Regulations. Notably, the company has announced it will cease its existing IT & Software consulting business operations. Given the company's micro-cap status (Rs 11 Cr market cap) and TTM revenue of only Rs 1 Cr, this total change in leadership and business direction is highly material.
- Management and control transition to Harmony Remedies India Private Limited effective August 13, 2026
- Outgoing promoters Rahul Dilip Shah and Rekha Rani Sarawgi to cease being promoters
- Company officially announced it will cease to be engaged in the IT & Software consulting business
- Board meeting for approval concluded in 18 minutes on August 12, 2026
- Rahul Dilip Shah's shareholding to be reclassified into the Public category
N2N Technologies reported a weak set of results for Q1 FY27, with revenue from operations falling 54.3% YoY to ₹15.20 Lacs from ₹33.28 Lacs. The net loss widened significantly to ₹12.49 Lacs compared to a loss of ₹1.70 Lacs in the corresponding quarter of the previous year. A critical concern is that employee benefit expenses at ₹22.30 Lacs alone exceeded the total revenue for the quarter. The company remains a micro-cap with a market capitalization of approximately ₹11 Cr and continues to struggle with negative operating margins.
- Revenue from operations declined 54.3% YoY to ₹15.20 Lacs from ₹33.28 Lacs.
- Net loss for the quarter widened to ₹12.49 Lacs, up from a loss of ₹1.70 Lacs in Q1 FY26.
- Employee benefit expenses stood at ₹22.30 Lacs, representing 146.7% of the total quarterly revenue.
- Total expenses of ₹27.69 Lacs were nearly double the total income of ₹15.20 Lacs.
- Earnings Per Share (EPS) worsened to ₹(0.39) from ₹(0.05) in the year-ago period.
N2N Technologies has scheduled a board meeting for August 12, 2026, to approve its Q1 FY27 financial results and formalize a change in management and promoter control. This transition follows a recently concluded Open Offer, which is a significant event for a micro-cap company with a market capitalization of only ₹11 Cr. The board will also consider the appointment of new directors as part of this change in control. Given the company's TTM revenue of just ₹1 Cr and a TTM loss of ₹3 Cr, this change in leadership is a critical development for potential business restructuring.
- Board meeting scheduled for August 12, 2026, to approve Q1 FY27 results.
- Formal change of Management and Control of the company to be considered.
- Change of Promoters following the recently concluded Open Offer.
- Appointment of new Directors to the board pursuant to the change in control.
- Company reported a significant loss of ₹2.79 Cr in the most recent quarter (Mar 2026).
நிறுவனச் சுயவிவரம்
நிதிச் செயல்திறன்
இந்த நிறுவனத்துக்கான நிதிப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
செயல்பாட்டு உந்துசக்திகள்
இந்த நிறுவனத்திற்கான செயல்பாட்டுப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
வியூக வளர்ச்சி
இந்த நிறுவனத்துக்கான வியூக வளர்ச்சிப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
வெளிப்புறக் காரணிகள்
இந்த நிறுவனத்துக்கு வெளிப்புறக் காரணிகளின் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
ஒழுங்குமுறை & நிர்வாகம்
இந்த நிறுவனத்திற்கான ஒழுங்குமுறைப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
அபாயப் பகுப்பாய்வு
இந்நிறுவனத்துக்கான அபாய பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
